Core Insights - The company reported a revenue of 1.321 billion yuan for the year 2024, representing a year-on-year growth of 10.16%, while the net profit attributable to shareholders decreased by 22.39% to 62.6375 million yuan [1] - The company invested 118 million yuan in R&D, accounting for 8.95% of its revenue, focusing on technological innovation and global expansion to strengthen its core competitiveness and promote sustainable development [1] Group 1: Enzyme Business - The enzyme segment achieved a revenue of 505 million yuan, reflecting a year-on-year increase of 14.34% [1] - The company has established four efficient protein expression systems and corresponding large-scale fermentation systems, which are crucial for the development of microbial production strains [1] Group 2: AI Integration and Animal Health - The company is exploring the deep integration of AI technology with biomanufacturing, establishing an AI technology development and application laboratory to enhance enzyme protein optimization and intelligent fermentation [2] - The company has built a comprehensive empowerment platform for animal health, providing systematic solutions covering animal nutrition, health breeding, and disease management [2] Group 3: Production Capacity and Future Plans - The company’s technology center and various production projects have commenced operations, with the production line for refined enzyme products expected to be operational by August 2025, indicating a systematic capacity layout across its business segments [2] - The company aims to support biomanufacturing with core technologies and provide clean energy solutions for traditional industries, focusing on multiple sectors including agriculture, food, health, and environmental protection [2]